PD-1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides/Sezary syndrome

被引:8
作者
Lewis, Natasha E. [1 ]
Gao, Qi [1 ]
Petrova-Drus, Kseniya [1 ,2 ]
Pulitzer, Melissa [3 ]
Sigler, Allison [1 ]
Baik, Jeeyeon [1 ]
Moskowitz, Alison J. [4 ]
Horwitz, Steven M. [4 ]
Dogan, Ahmet [1 ]
Roshal, Mikhail [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Pathol, Hematopathol Serv, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Pathol, Diagnost Mol Pathol Serv, New York, NY 10065 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, Dermatopathol Serv, New York, NY 10065 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, New York, NY 10065 USA
关键词
flow cytometry; mycosis fungoides; PD-1; Sezary syndrome; PROGRAMMED DEATH-1; DIFFERENTIAL EXPRESSION; T-CELLS; LYMPHOMA; CLASSIFICATION; CLONALITY; BIOPSIES; PATHWAY; MARKERS;
D O I
10.1002/cyto.b.22070
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background Accurate Sezary cell detection in peripheral blood of mycosis fungoides/Sezary syndrome (MF/SS) patients by flow cytometry can be difficult due to overlapping immunophenotypes with normal T cells using standard markers. We assessed the utility of programmed death-1 (PD-1/CD279), a transmembrane protein expressed in some hematopoietic cells, for identification and quantitation of circulating Sezary cells among established markers using flow cytometry. Methods 50 MF/SS and 20 control blood samples were immunophenotyped by flow cytometry. Principal component analysis (PCA) assessed contributions of antigens to separation of abnormal from normal T cell populations. PD-1 was assessed over time in blood and bone marrow of available MF/SS cases. Results Normal CD4+ T cells showed dim/intermediate to absent PD-1 expression. PD-1 in Sezary cells was informatively brighter (>= 1/3 log) than internal normal CD4+ T cells in 39/50 (78%) cases. By PCA, PD-1 ranked 3rd behind CD7 and CD26 in population separation as a whole; it ranked in the top 3 markers in 32/50 (64%) cases and 1st in 4/50 (8%) cases when individual abnormal populations were compared to total normal CD4+ T cells. PD-1 clearly separated Sezary from normal CD4+ T cells in 15/26 (58%, 30% of total) cases with few and subtle alterations of pan-T cell antigens/CD26 and was critical in 6 (12% of total), without which identification and quantification were significantly affected or nearly impossible. PD-1 remained informative in blood/bone marrow over time in most patients. Conclusions PD-1 significantly contributes to accurate flow cytometric Sezary cell assessment in a routine Sezary panel.
引用
收藏
页码:189 / 198
页数:10
相关论文
共 42 条
  • [31] Increased Programmed Death-1 Expression on CD4+ T Cells in Cutaneous T-Cell Lymphoma Implications for Immune Suppression
    Samimi, Sara
    Benoit, Bernice
    Evans, Katherine
    Wherry, E. John
    Showe, Louise
    Wysocka, Maria
    Rook, Alain H.
    [J]. ARCHIVES OF DERMATOLOGY, 2010, 146 (12) : 1382 - 1388
  • [32] Blockade of programmed cell death protein 1 (PD-1) in Sezary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation
    Saulite, Ieva
    Ignatova, Desislava
    Chang, Yun-Tsan
    Fassnacht, Christina
    Dimitriou, Florentia
    Varypataki, Eleni
    Anzengruber, Florian
    Nageli, Mirjam
    Cozzio, Antonio
    Dummer, Reinhard
    Scarisbrick, Julia
    Pascolo, Steve
    Hoetzenecker, Wolfram
    Bobrowicz, Malgorzata
    Guenova, Emmanuella
    [J]. ONCOIMMUNOLOGY, 2020, 9 (01):
  • [33] T-cell clones of uncertain significance are highly prevalent and show close resemblance to T-cell large granular lymphocytic leukemia. Implications for laboratory diagnostics
    Shi, Min
    Olteanu, Horatiu
    Jevremovic, Dragan
    He, Rong
    Viswanatha, David
    Corley, Heidi
    Horna, Pedro
    [J]. MODERN PATHOLOGY, 2020, 33 (10) : 2046 - 2057
  • [34] Single Antibody Detection of T-Cell Receptor αβ Clonality by Flow Cytometry Rapidly Identifies Mature T-Cell Neoplasms and Monotypic Small CD8-Positive Subsets of Uncertain SignificanceKey terms
    Shi, Min
    Jevremovic, Dragan
    Otteson, Gregory E.
    Timm, Michael M.
    Olteanu, Horatiu
    Horna, Pedro
    [J]. CYTOMETRY PART B-CLINICAL CYTOMETRY, 2020, 98 (01) : 99 - 107
  • [35] EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes
    van Dongen, J. J. M.
    Lhermitte, L.
    Boettcher, S.
    Almeida, J.
    van der Velden, V. H. J.
    Flores-Montero, J.
    Rawstron, A.
    Asnafi, V.
    Lecrevisse, Q.
    Lucio, P.
    Mejstrikova, E.
    Szczepanski, T.
    Kalina, T.
    de Tute, R.
    Brueggemann, M.
    Sedek, L.
    Cullen, M.
    Langerak, A. W.
    Mendonca, A.
    Macintyre, E.
    Martin-Ayuso, M.
    Hrusak, O.
    Vidriales, M. B.
    Orfao, A.
    [J]. LEUKEMIA, 2012, 26 (09) : 1908 - 1975
  • [36] Update on erythrodermic cutaneous T-cell lymphoma: Report of the International Society for Cutaneous Lymphomas
    Vonderheid, EC
    Barnengo, MG
    Burg, G
    Duvic, M
    Heald, P
    Laroche, L
    Olsen, E
    Pittelkow, M
    Russell-Jones, R
    Takigawa, M
    Willemze, R
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (01) : 95 - 106
  • [37] Programmed death 1 is expressed in cutaneous infiltrates of mycosis fungoides and Sezary syndrome
    Wada, David A.
    Wilcox, Ryan A.
    Harrington, Susan M.
    Kwon, Eugene D.
    Ansell, Stephen M.
    Comfere, Nneka I.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (03) : 325 - 327
  • [38] WHO-EORTC classification for cutaneous lymphomas
    Willemze, R
    Jaffe, ES
    Burg, G
    Cerroni, L
    Berti, E
    Swerdlow, SH
    Ralfkiaer, E
    Chimenti, S
    Diaz-Perez, JL
    Duncan, LM
    Grange, F
    Harris, NL
    Kempf, W
    Kerl, H
    Kurrer, M
    Knobler, R
    Pimpinelli, N
    Sander, C
    Santucci, M
    Sterry, W
    Vermeer, MH
    Wechsler, J
    Whittaker, S
    Meijer, CJLM
    [J]. BLOOD, 2005, 105 (10) : 3768 - 3785
  • [39] The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas
    Willemze, Rein
    Cerroni, Lorenzo
    Kempf, Werner
    Berti, Emilio
    Facchetti, Fabio
    Swerdlow, Steven H.
    Jaffe, Elaine S.
    [J]. BLOOD, 2019, 133 (16) : 1703 - 1714
  • [40] Prognostic and clinicopathological significance of PD-1/PD-Li expression in the tumor microenvironment and neoplastic cells for lymphoma
    Xie, Mixue
    Huang, Xianbo
    Ye, Xiujin
    Qian, Wenbin
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 77